paragraph

Lupin vs Torrent Pharma: Which ones should you choose in the current market scenario?

In the last one year, both Lupin and Torrent Pharma have outperformed the benchmark Nifty Pharma, however, the former is a slightly better performer between the two. Lupin has rallied over 43% in the last 1 year while Torrent has advanced around 32% in this period. 

These 13 mid and small-cap stocks trading under ₹100 delivered stellar returns in the last one year

5G subscriptions to touch 1.5 billion in 2023

Credit card market experiences explosive growth

23 Nifty 500 stocks have delivered returns up to 90% in 2023 so far

Global markets in May 2023: A snapshot

Trends in insurance sector

Dynamic growth of the warehousing market in India

Market capitalisation of BSE listed companies touches record high

Performance of equity in the long run

MF central: Manage accounts with multiple fund houses at one unified platform; Here's how

Holding a number of mutual funds in a number of AMCs is not uncommon. It is, therefore, vital to manage all accounts with ease and comfort

Stock Check: JSW Infra jumps almost 100% from IPO price in 5 months; should you still buy?

Currently trading at around ₹236, the newly listed JSW Infra has surged almost 100 percent jump from its IPO price of ₹119 in less than 5 months. Technical and fundamental experts suggest if you should still buy the infra stock.

Axis Mobile App ranks top position on NPS leaderboard

According to a survey, Consumer awareness was most notable for payment platforms such as Paytm, Google Pay, and PhonePe. However, when it comes to Net Promoter Score, Axis Mobile App claims the top position with a score of 59, followed by ICICI Bank's iMobile Pay, and then BHIM.

Weekend Wrap: From Trent to Adani Power, top news and market movers this week: 27 October 2023

The stock market cycle is always a few months ahead of the economic cycle.

From top news makers to market performance, here's the market wrap for the week ended 27 October 2023.

Why rebalancing a portfolio provides a safety net against volatility?

Investing isn't a 'set it and forget it' game.

Rebalancing a portfolio provides a safety net by helping control volatility and minimizing the impact of market downturns, even though it may not always yield higher returns compared to an unbalanced, equity-heavy approach

Lupin vs Torrent Pharma: Which ones should you choose in the current market scenario?

In the last one year, both Lupin and Torrent Pharma have outperformed the benchmark Nifty Pharma, however, the former is a slightly better performer between the two. Lupin has rallied over 43% in the last 1 year while Torrent has advanced around 32% in this period.

Topics to follow